دورية أكاديمية
Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program.
العنوان: | Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program. |
---|---|
المؤلفون: | Hasan, Ghadeer, Ferucci, Elizabeth D, Buyon, Jill P, Belmont, H Michael, Salmon, Jane E, Askanase, Anca, Bathon, Joan M, Geraldino-Pardilla, Laura, Ali, Yousaf, Ginzler, Ellen M, Putterman, Chaim, Gordon, Caroline, Helmick, Charles G, Parton, Hilary, Izmirly, Peter M |
المصدر: | Rheumatology; Aug2023, Vol. 62 Issue 8, p2845-2849, 5p |
مصطلحات موضوعية: | PUBLIC health surveillance, REPORTING of diseases, CONFIDENCE intervals, NOSOLOGY, CONNECTIVE tissue diseases, HUMAN services programs, DISEASE prevalence, RESEARCH funding |
مصطلحات جغرافية: | UNITED States |
مستخلص: | Objective Epidemiological data for MCTD are limited. Leveraging data from the Manhattan Lupus Surveillance Program (MLSP), a racially/ethnically diverse population-based registry of cases with SLE and related diseases including MCTD, we provide estimates of the prevalence and incidence of MCTD. Methods MLSP cases were identified from rheumatologists, hospitals and population databases using a variety of International Classification of Diseases, Ninth Revision codes. MCTD was defined as one of the following: fulfilment of our modified Alarcon-Segovia and Kahn criteria, which required a positive RNP antibody and the presence of synovitis, myositis and RP; a diagnosis of MCTD and no other diagnosis of another CTD; and a diagnosis of MCTD regardless of another CTD diagnosis. Results Overall, 258 (7.7%) cases met a definition of MCTD. Using our modified Alarcon-Segovia and Kahn criteria for MCTD, the age-adjusted prevalence was 1.28 (95% CI 0.72, 2.09) per 100 000. Using our definition of a diagnosis of MCTD and no other diagnosis of another CTD yielded an age-adjusted prevalence and incidence of MCTD of 2.98 (95% CI 2.10, 4.11) per 100 000 and 0.39 (95% CI 0.22, 0.64) per 100 000, respectively. The age-adjusted prevalence and incidence were highest using a diagnosis of MCTD regardless of other CTD diagnoses and were 16.22 (95% CI 14.00, 18.43) per 100 000 and 1.90 (95% CI 1.49, 2.39) per 100 000, respectively. Conclusions The MLSP provided estimates for the prevalence and incidence of MCTD in a diverse population. The variation in estimates using different case definitions is reflective of the challenge of defining MCTD in epidemiologic studies. [ABSTRACT FROM AUTHOR] |
Copyright of Rheumatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
قاعدة البيانات: | Complementary Index |
كن أول من يترك تعليقا!